Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2016-10-27 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VIROFLAY (78220), Yvelines
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES TROIS GARES : revenue, balance sheet and financial ratios
PHARMACIE DES TROIS GARES is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VIROFLAY (78220),
this company of category PME
shows in 2023 a net income positive of 146 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES TROIS GARES (SIREN 823429816)
Indicator
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
145 991 €
156 150 €
127 460 €
119 662 €
90 931 €
64 032 €
-23 597 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE DES TROIS GARES generates positive net income of 146 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
145 991 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 106%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
106.179%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
42.279%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES TROIS GARES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
Debt ratio
-4813.183
2575.436
754.851
369.354
226.72
147.721
106.179
Financial autonomy
-1.789
3.237
10.167
18.343
26.37
34.714
42.279
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
106.182023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average-15 pts over 3 years
In 2023, the debt ratio of PHARMACIE DES TROIS GARES (106.18) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
42.28%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average+16 pts over 3 years
In 2023, the financial autonomy of PHARMACIE DES TROIS GARES (42.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 290.09. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
290.091
Liquidity indicators evolution PHARMACIE DES TROIS GARES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
149.773
165.525
183.661
196.624
217.893
244.229
290.091
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
290.092023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Excellent+15 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE DES TROIS GARES (290.09) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE DES TROIS GARES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DES TROIS GARES is estimated at
1 722 617 €
(range 1 047 606€ - 2 421 613€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1047k€1722k€2421k€
1 722 617 €Range: 1 047 606€ - 2 421 613€
NAF 5 année 2023
Valuation method used
Net Income Multiple
145 991 €
×
11.8x
=1 722 617 €
Range: 1 047 606€ - 2 421 613€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES TROIS GARES with other companies in the same sector:
Frequently asked questions about PHARMACIE DES TROIS GARES
What is the revenue of PHARMACIE DES TROIS GARES ?
The revenue of PHARMACIE DES TROIS GARES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DES TROIS GARES profitable?
Yes, PHARMACIE DES TROIS GARES generated a net profit of 146 k€ in 2023.
Where is the headquarters of PHARMACIE DES TROIS GARES ?
The headquarters of PHARMACIE DES TROIS GARES is located in VIROFLAY (78220), in the department Yvelines.
Where to find the tax return of PHARMACIE DES TROIS GARES ?
The tax return of PHARMACIE DES TROIS GARES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES TROIS GARES operate?
PHARMACIE DES TROIS GARES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart